Cemiplimab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Colorectal Cancer.

Cabometyx is under clinical development by Exelixis and currently in Phase II for Salivary Gland Cancer. According to GlobalData, Phase II drugs for Salivary Gland Cancer have a 14% phase transition ...

Prostate cancer ranks among the most common health challenges men face worldwide. While medical advances continue to improve treatment outcomes, the e ...

Prostate cancer is a health issue that impacts individuals worldwide, and choosing the best treatment can be difficult, given ...

During an in-person Community Case Forum event in Miami, Florida, Mike Cusnir, MD, discussed the ARANOTE study outcomes ...

Discover the study supports the potential of neoadjuvant androgen deprivation therapy as an adjunctive therapy in HRLPC.

Oncologists are giving a thumbs up to physical exercise for breast cancer patients: it boosts quality of life and prognosis.

Advanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called ...

American Urological Association (AUA) annual meeting in San Antonio strongly emphasized diversity, equity, and inclusion, as ...

A team of researchers at Roswell Park Comprehensive Cancer Center, led by Dhyan Chandra, Ph.D., has discovered a new therapeutic target for neuroendocrine prostate cancer, a rare and hard-to-treat ...

Sheel Patel, a board certified physician in hematology, oncology, and internal medicine, spoke with Healthline about how prostate cancer affects Black men, including rate of diagnosis, survival ...

Although the risk of breast cancer gradually increases with use, it decreases once hormone therapy is stopped. On the other hand, a higher risk for uterine cancer also exists when menopausal ...